These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23394559)

  • 1. The use of transient expression systems for the rapid production of virus-like particles in plants.
    Thuenemann EC; Lenzi P; Love AJ; Taliansky M; Bécares M; Zuñiga S; Enjuanes L; Zahmanova GG; Minkov IN; Matić S; Noris E; Meyers A; Hattingh A; Rybicki EP; Kiselev OI; Ravin NV; Eldarov MA; Skryabin KG; Lomonossoff GP
    Curr Pharm Des; 2013; 19(31):5564-73. PubMed ID: 23394559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.
    Hemmati F; Hemmati-Dinarvand M; Karimzade M; Rutkowska D; Eskandari MH; Khanizadeh S; Afsharifar A
    Biotechnol Lett; 2022 Jan; 44(1):45-57. PubMed ID: 34837582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant-derived virus-like particles as vaccines.
    Chen Q; Lai H
    Hum Vaccin Immunother; 2013 Jan; 9(1):26-49. PubMed ID: 22995837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
    Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V
    Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.
    Kushnir N; Streatfield SJ; Yusibov V
    Vaccine; 2012 Dec; 31(1):58-83. PubMed ID: 23142589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-like particles produced in plants as potential vaccines.
    Scotti N; Rybicki EP
    Expert Rev Vaccines; 2013 Feb; 12(2):211-24. PubMed ID: 23414411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
    Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
    J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Molecular Biology Approaches for the Production of Poliovirus Virus-Like Particles Using
    Sherry L; Grehan K; Snowden JS; Knight ML; Adeyemi OO; Rowlands DJ; Stonehouse NJ
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32161150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
    Lindsay BJ; Bonar MM; Costas-Cancelas IN; Hunt K; Makarkov AI; Chierzi S; Krawczyk CM; Landry N; Ward BJ; Rouiller I
    Vaccine; 2018 Apr; 36(16):2147-2154. PubMed ID: 29550194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus.
    Wu X; Zhai X; Lai Y; Zuo L; Zhang Y; Mei X; Xiang R; Kang Z; Zhou L; Wang H
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.
    Weiwei G; Xuexing Z; Chong W; Yongkun Z; Qi W; Hualei W; Gary W; Ying X; Haijun W; Zengguo C; Na F; Hang C; Tiecheng W; Yuwei G; Junjie S; Songtao Y; Xianzhu X
    J Med Virol; 2017 Dec; 89(12):2069-2074. PubMed ID: 28402024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
    Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
    Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Assembling Plant-Derived Vaccines Against Papillomaviruses.
    Noris E
    Methods Mol Biol; 2018; 1776():85-95. PubMed ID: 29869236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
    Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
    Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate.
    Fontana D; Kratje R; Etcheverrigaray M; Prieto C
    Vaccine; 2015 Aug; 33(35):4238-46. PubMed ID: 25869890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.